CAR T-cell therapy
2020/00865
Phase 1 mab active
Quick answer
CAR T-cell therapy for Lymphoblastic Leukemia, Acute, Childhood is a Phase 1 program (mab) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Lymphoblastic Leukemia, Acute, Childhood
- Phase
- Phase 1
- Modality
- mab
- Status
- active